Your browser doesn't support javascript.
loading
Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.
Delemarre, Eveline M; van Hoorn, Laura; Bossink, Aik W J; Drylewicz, Julia; Joosten, Simone A; Ottenhoff, Tom H M; Akkerman, Onno W; Goletti, Delia; Petruccioli, Elisa; Navarra, Assunta; van den Broek, Brigitte T A; Paardekooper, Sanne P A; van Haeften, Ineke; Koenderman, Leo; Lammers, Jan-Willem J; Thijsen, Steven F T; Hofland, Regina W; Nierkens, Stefan.
Affiliation
  • Delemarre EM; Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands.
  • van Hoorn L; Platform Immune Monitoring (PIM), University Medical Center Utrecht, Utrecht, Netherlands.
  • Bossink AWJ; Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands.
  • Drylewicz J; Department of Respiratory Medicine and Tuberculosis, University Medical Center Utrecht, Utrecht, Netherlands.
  • Joosten SA; Department of Respiratory Medicine and Tuberculosis, Diakonessenhuis, Utrecht, Netherlands.
  • Ottenhoff THM; Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands.
  • Akkerman OW; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • Goletti D; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • Petruccioli E; Department of Respiratory Medicine and Tuberculosis, University Medical Center Groningen, Groningen, Netherlands.
  • Navarra A; Translational Research Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases-IRCCS L. Spallanzani, Rome, Italy.
  • van den Broek BTA; Translational Research Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases-IRCCS L. Spallanzani, Rome, Italy.
  • Paardekooper SPA; Translational Research Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases-IRCCS L. Spallanzani, Rome, Italy.
  • van Haeften I; Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands.
  • Koenderman L; Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands.
  • Lammers JJ; Department of Tuberculosis, Municipal Public Health Service, Utrecht, Netherlands.
  • Thijsen SFT; Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands.
  • Hofland RW; Department of Respiratory Medicine and Tuberculosis, University Medical Center Utrecht, Utrecht, Netherlands.
  • Nierkens S; Department of Respiratory Medicine and Tuberculosis, University Medical Center Utrecht, Utrecht, Netherlands.
Front Immunol ; 12: 725447, 2021.
Article in En | MEDLINE | ID: mdl-34691031

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND Database: MEDLINE Main subject: Adenosine Deaminase / Vascular Endothelial Growth Factor A / Chemokine CCL1 / Chemokine CXCL10 / Latent Tuberculosis Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Front Immunol Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND Database: MEDLINE Main subject: Adenosine Deaminase / Vascular Endothelial Growth Factor A / Chemokine CCL1 / Chemokine CXCL10 / Latent Tuberculosis Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Front Immunol Year: 2021 Document type: Article